1.
ADME/PK Laboratory - www.biofocusdpi.com
The ADME/PK Laboratory consultative approach utilizes industry ... The adaptable ADME/PK Laboratory team has experience with many analytical procedures ...
2.
What Lies in the Future for in silico ADME?
File Format: PDF/Adobe Acrobat - View as HTML able us to be confident that the role in silico ADME will play in drug dis- covery will become firmly established.Our confidence in this prediction comes ...
3.
What Lies in the Future for in silico ADME?
File Format: PDF/Adobe Acrobat - View as HTML able us to be confident that the role in silico ADME will play in drug dis- covery will become firmly established.Our confidence in this prediction comes ...
4.
Target screening - www.biofocusdpi.com
Wide range of assay expertise. • High-content screening ... Contact us to learn more about our target screening platform and assay expertise. ...
5.
BioFocus DPI enhances high-content screening capabilities - www ...
As part of BioFocus DPI’s Intelligent Screening platform, high-content screening .... 14-3-2007 |, BioFocus DPI to supply chemical compound sets to Johnson ...
6.
BioFocus DPI announces exclusive agreement with Upstate for ...
BioFocus DPI announces exclusive agreement with Upstate for marketing and sales of ... has signed an exclusive marketing & sales agreement with Upstate, ...
7.
BioFocus DPI launches GPCR SARfari - www.biofocusdpi.com
BioFocus DPI is launching a new version of the GPCR SARfari discovery tool ... 9-12-2008 |, BioFocus DPI and Dart Neuroscience LLC sign drug discovery and ...
8.
GPCR libraries - www.biofocusdpi.com
The core(s) has been selected to target a specific sub-set of GPCR's such as aminergic, peptidic, purinergic or Family B GPCRs and contain two or more ...
9.
Management Team - www.biofocusdpi.com
Management Team. ... molecular immunology at Harvard University. Related links. Galapagos Executive Team · Galapagos Board of Directors · BioFocus DPI Home ...
10.
Ion channel screening - www.biofocusdpi.com
Until recently, ion channel drug discovery has been restricted by a deficiency of molecular and structural information, sub-optimal screening technologies ...